ArticleActive
Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (DL37764)
A56169
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: December 17, 2018
Updated: December 31, 2025
Policy Summary
This document (A56169) is a responses-to-comments record for the MolDX Draft LCD DL37764 concerning multiplex nucleic acid amplified tests for respiratory viral panels and does not establish coverage criteria itself. For specific indications, limitations, documentation requirements, and frequency limits, consult the referenced LCD DL37764 (MolDX) and related MAC policy documents.
Coverage Criteria Preview
Key requirements from the full policy
"This document is a response-to-comments summary for the MolDX Draft LCD DL37764 (Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels) and does not itself define coverage criteria; r..."
Sign up to see full coverage criteria, indications, and limitations.